Table 3.
Studies included in the review.
| Study ID | Title | First Author |
|---|---|---|
| 1 | Multi organ impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study [14]. | Dennis, A. |
| 2 | Post COVID-19 squealae: A prospective observational study from Northern India [15]. | Naik, S. |
| 3 | Post-acute COVID-19 Syndrome Negatively Impacts Physical Function, Cognitive Function, Health-Related Quality of Life, and Participation [16]. | Tabacof, L. |
| 4 | Long-term sequelae are highly prevalent one year after hospitalization for severe COVID-19 [17]. | Bellan, M. |
| 5 | Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID-19 [18]. | Munblit, D. |
| 6 | Risk Factors Associated with Long COVID Syndrome: A Retrospective Study [19]. | Asadi-Pooya, A.A. |
| 7 | Long-term clinical follow-up of patients suffering from moderate-to-severe COVID-19 infection: a mono centric prospective observational cohort study [20]. | Darcis, G |
| 8 | Long-Term Evolution of Malnutrition and Loss of Muscle Strength after COVID-19: A Major and Neglected Component of Long COVID-19 [21]. | Gérard, M. |
| 9 | Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome [22]. | Cervia, C. |
| 10 | Persistent symptoms and decreased health-related quality of life after symptomatic paediatric COVID-19: A prospective study in a Latin American tertiary hospital [23]. | Fink, T.T. |
| 11 | Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalization in the UK: a prospective observational study [24]. | Evans, R.A. |
| 12 | Chronic Fatigue and Post exertional Malaise in People Living With Long COVID: An Observational Study [25]. | Twomey, R. |
| 13 | Factors Associated with Post-Acute Sequalae of SARS-CoV-2 (PASC) After Diagnosis of Symptomatic COVID-19 in the Inpatient and Outpatient Setting in a Diverse Cohort [26]. | Yoo, S.M. |
| 14 | Symptoms Experienced at the Acute Phase of SARS-CoV-2 Infection as Risk Factor of Long-term Post-COVID Symptoms: The LONG-COVID-EXP-CM Multicentre Study [27]. | Fernández-de-Las-Peñas, C. |
| 15 | Predictors of chronic COVID-19 symptoms in a community-based cohort of adults [28]. | Silverberg, J.I. |
| 16 | Post-acute COVID-19 condition in Saudi Arabia: A national representative study [29]. | AlRadini, F.A. |
| 17 | Long COVID symptoms in SARS-CoV-2-positive children aged 0–14 years and matched controls in Denmark (LongCOVIDKidsDK): a national, cross-sectional study [30]. | Kikkenborg Berg, S. |
| 18 | Post-sequalae one year after hospital discharge among older COVID-19 patients: A multi-centre prospective cohort study [31]. | Fang, X. |
| 19 | The long-term functioning status of COVID-19 survivors: a prospective observational evaluation of a cohort of patients surviving hospitalization [32]. | Battistella, L.R. |
| 20 | Long COVID-19 symptoms: Clinical characteristics and recovery rate among non-severe outpatients over a six-month follow-up [33]. | Seang, S. |
| 21 | Health Status, Persistent Symptoms, and Effort Intolerance One Year After Acute COVID-19 Infection [34]. | Kingery, J.R. |
| 22 | Associations between persistent symptoms after mild COVID-19 and long-term health status, quality of life, and psychological distress [35]. | Han, J.H. |
| 23 | Long COVID 12 months after discharge: persistent symptoms in patients hospitalised due to COVID-19 and patients hospitalized due to other causes-a multicentre cohort study [36]. | Rivera-Izquierdo, M. |
| 24 | Fatigue and Dyspnoea as Main Persistent Post-COVID-19 Symptoms in Previously Hospitalized Patients: Related Functional Limitations and Disability [37]. | Fernández-de-Las-Peñas, C. |
| 25 | Risk factors for fatigue and impaired function eight months after hospital admission with COVID-19 [38]. | Schouborg, L.B. |
| 26 | Prospective Evaluation of Autonomic Dysfunction in Post-Acute Sequela of COVID-19 [39]. | Jamal, S.M. |
| 27 | Neurocognitive Profiles in Patients With Persisting Cognitive Symptoms Associated With COVID-19 [40]. | Krishnan, K. |
| 28 | Long COVID in hospitalized and non-hospitalized patients in a large cohort in Northwest Spain, a prospective cohort study [41]. | Pérez-González, A. |
| 29 | Sequelae, persistent symptomatology and outcomes after COVID-19 hospitalization: the ANCOHVID multicentre 6-month follow-up study [42]. | Romero-Duarte, Á. |
| 30 | Six-Month Outcomes in Patients Hospitalized with Severe COVID-19 [43]. | Horwitz, L.I. |
| 31 | Long-COVID’: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalization for COVID-19 [44]. | Mandal, S. |
| 32 | Physical, cognitive, and mental health impacts of COVID-19 after hospitalization (PHOSP-COVID): a UK multicentre, prospective cohort study [45]. | Evans, R.A. |
| 33 | Post-acute sequelae of COVID-19: Evidence of mood and cognitive impairment [46]. | Lamontagne, S.J. |